Credit: Getty Images. Insulin glargine 300 Units/mL was found to be comparable to insulin glargine 100 Units/mL in providing effective glycemic control in pediatric patients with type 1 diabetes.

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

--- First 200 units/ml rapid-acting insulin product for the treatment of diabetes INDIANAPOLIS, Oct. 3, 2014 /PRNewswire/ -- Eli Lilly and Company today announced that the European Commission has ...